Sartorius Stedim Biotech S.A. (EPA:DIM)
170.60
+0.50 (0.29%)
Jul 31, 2026, 11:54 AM CET
Sartorius Stedim Biotech Employees
Sartorius Stedim Biotech had 10,477 employees as of June 30, 2026. The number of employees increased by 447 or 4.46% compared to the same quarter last year.
Employees
10,477
Change
447
Growth
4.46%
Revenue / Employee
€286,828
Profits / Employee
€27,928
Market Cap
16.55B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 10,477 | 447 | 4.46% | 10,477 | 0 |
| Mar 31, 2026 | 10,456 | 495 | 4.97% | 10,456 | 0 |
| Dec 31, 2025 | 10,265 | 364 | 3.68% | 9,753 | 512 |
| Sep 30, 2025 | 10,134 | 52 | 0.52% | 10,134 | 0 |
| Jun 30, 2025 | 10,030 | -352 | -3.39% | 10,030 | 0 |
| Mar 31, 2025 | 9,961 | -532 | -5.07% | 9,961 | 0 |
| Dec 31, 2024 | 9,901 | -761 | -7.14% | 9,409 | 492 |
| Sep 30, 2024 | 10,082 | -767 | -7.07% | 10,082 | 0 |
| Jun 30, 2024 | 10,382 | -753 | -6.76% | 10,382 | 0 |
| Mar 31, 2024 | 10,493 | -1,441 | -12.07% | 10,493 | 0 |
| Dec 31, 2023 | 10,662 | -1,272 | -10.66% | 10,662 | 0 |
| Sep 30, 2023 | 10,849 | -1,093 | -9.15% | 10,849 | 0 |
| Jun 30, 2023 | 11,135 | -807 | -6.76% | 11,135 | 0 |
| Dec 31, 2022 | 11,934 | 1,525 | 14.65% | 11,934 | 0 |
| Jun 30, 2022 | 11,942 | 3,196 | 36.54% | 11,942 | 0 |
| Mar 31, 2022 | 11,400 | 3,200 | 39.02% | 11,400 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 155,975 |
| emeis Société anonyme | 84,586 |
| Sanofi | 74,846 |
| Clariane SE | 70,685 |
| Eurofins Scientific SE | 65,000 |
| Ramsay Générale de Santé | 40,000 |
| bioMérieux | 15,226 |
| Virbac | 6,442 |
Sartorius Stedim Biotech News
- 7 days ago - Sartorius Stedim Biotech Earnings Call Transcript: Q2 2026 - Transcripts
- 7 days ago - Sartorius Stedim Biotech Earnings release: Q2 2026 - Filings
- 7 days ago - Sartorius Stedim Biotech Quarterly report: Q2 2026 - Filings
- 7 days ago - Sartorius Stedim Biotech Slides: Q2 2026 - Filings
- 8 days ago - Sartorius Stedim Biotech Q2 Profit & Sales Rise; Backs FY26 Outlook - Nasdaq
- 3 months ago - Sartorius Stedim Biotech Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - Sartorius Stedim Biotech Earnings release: Q1 2026 - Filings
- 3 months ago - Sartorius Stedim Biotech Slides: Q1 2026 - Filings